Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-20-000897
Filing Date
2020-01-13
Accepted
2020-01-13 08:07:20
Documents
3
Period of Report
2020-01-13

Document Format Files

Seq Description Document Type Size
1 RR NEW DIRECTOR bntx-6k_20200113.htm 6-K 17498
2 EX-99.1 PRESS RELEASE bntx-ex991_6.htm EX-99.1 15526
3 GRAPHIC g5xtztmfmxhc000001.jpg GRAPHIC 41593
  Complete submission text file 0001564590-20-000897.txt   91389
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190847081
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39081 | Film No.: 20522851
SIC: 2836 Biological Products, (No Diagnostic Substances)